Propel Bio Management, LLC 13F holdings
Propel Bio Management, LLC reported 29 positions with a total reported value of $191.1M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-13. Top holdings by reported value: PAGP PLAINS GP HOLDINGS LP-CL (16.2%), ACHV ACHIEVE LIFE SCIENCES INC (13.8%), CORT CORCEPT THERAPEUTICS INC (6.2%), PHAT PHATHOM PHARMACEUTICALS I (6.0%), DCTH DELCATH SYSTEMS INC (5.7%). Against 2026-03-31 it opened 3 new positions and exited 12. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Propel Bio Management, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 29 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| PAGP PLAINS GP HOLDINGS LP-CL | 1,272,360 | $30.9M | 16.2% |
| ACHV ACHIEVE LIFE SCIENCES INC | 4,034,018 | $26.3M | 13.8% |
| CORT CORCEPT THERAPEUTICS INC | 136,499 | $11.9M | 6.2% |
| PHAT PHATHOM PHARMACEUTICALS I | 1,050,358 | $11.4M | 6.0% |
| DCTH DELCATH SYSTEMS INC | 871,460 | $11.0M | 5.7% |
| MIST MILESTONE PHARMACEUTICALS | 7,429,590 | $10.0M | 5.2% |
| CMPS COMPASS PATHWAYS PLC | 573,086 | $8.1M | 4.2% |
| KYTX KYVERNA THERAPEUTICS INC | 883,198 | $7.9M | 4.1% |
| ARTV ARTIVA BIOTHERAPEUTICS IN | 696,436 | $6.8M | 3.5% |
| ABEO ABEONA THERAPEUTICS INC | 983,070 | $6.1M | 3.2% |
| AQST AQUESTIVE THERAPEUTICS IN | 1,442,397 | $6.0M | 3.1% |
| PALI PALISADE BIO INC | 2,582,388 | $5.4M | 2.8% |
| IMUX IMMUNIC INC | 325,022 | $5.0M | 2.6% |
| IVA INVENTIVA SA - ADR | 1,281,212 | $4.8M | 2.5% |
| SABS SAB BIOTHERAPEUTICS INC | 1,076,578 | $4.2M | 2.2% |
| OBIO ORCHESTRA BIOMED HOLDINGS | 896,701 | $3.9M | 2.0% |
| CLDX CELLDEX THERAPEUTICS INC | 103,695 | $3.9M | 2.0% |
| ZVRA ZEVRA THERAPEUTICS INC | 253,544 | $3.6M | 1.9% |
| OCUL OCULAR THERAPEUTIX INC | 357,966 | $3.5M | 1.8% |
| FDMT 4D MOLECULAR THERAPEUTICS IN | 252,654 | $3.4M | 1.8% |
| OVID OVID THERAPEUTICS INC | 1,115,538 | $3.0M | 1.6% |
| EYPT EYEPOINT INC | 191,745 | $2.7M | 1.4% |
| UPB UPSTREAM BIO INC | 350,389 | $2.4M | 1.3% |
| SCYX SCYNEXIS INC | 543,478 | $2.2M | 1.2% |
| SLN SILENCE THERAPEUTICS PLC | 191,733 | $2.1M | 1.1% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 3 in all · reported value as of 2026-06-30
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 12 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| VOR VOR BIOPHARMA INC | 314,543 | $5.6M | 3.5% |
| VIRIDIAN THERAPEUTICS INC | 210,163 | $4.1M | 2.6% |
| OCS OCULIS HOLDING AG | 122,223 | $3.3M | 2.1% |
| TRVI TREVI THERAPEUTICS INC | 223,802 | $2.6M | 1.7% |
| CHRS COHERUS ONCOLOGY INC | 1,420,550 | $2.4M | 1.5% |
| KLRS KALARIS THERAPEUTICS INC | 295,771 | $1.7M | 1.1% |
| QURE UNIQURE NV | 104,772 | $1.7M | 1.1% |
| NUVB NUVATION BIO INC | 329,296 | $1.4M | 0.9% |
| EVMN EVOMMUNE INC | 55,664 | $1.3M | 0.8% |
| ALDX ALDEYRA THERAPEUTICS INC | 730,606 | $1.2M | 0.8% |
| CNTB CONNECT BIOPHARMA HLDGS LTD | 209,493 | $553.9K | 0.3% |
| MSLE SATELLOS BIOSCIENCE INC | 10,145 | $57.1K | <0.1% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| ARTV ARTIVA BIOTHERAPEUTICS IN | 146,369 | 696,436 | +375.8% | $6.8M |
| MIST MILESTONE PHARMACEUTICALS | 4,118,321 | 7,429,590 | +80.4% | $10.0M |
| PALI PALISADE BIO INC | 1,115,000 | 2,582,388 | +131.6% | $5.4M |
| AQST AQUESTIVE THERAPEUTICS IN | 710,988 | 1,442,397 | +102.9% | $6.0M |
| PHAT PHATHOM PHARMACEUTICALS I | 841,272 | 1,050,358 | +24.9% | $11.4M |
| KYTX KYVERNA THERAPEUTICS INC | 644,421 | 883,198 | +37.1% | $7.9M |
| IVA INVENTIVA SA - ADR | 724,678 | 1,281,212 | +76.8% | $4.8M |
| ACHV ACHIEVE LIFE SCIENCES INC | 3,786,425 | 4,034,018 | +6.5% | $26.3M |
| OVID OVID THERAPEUTICS INC | 921,457 | 1,115,538 | +21.1% | $3.0M |
| SABS SAB BIOTHERAPEUTICS INC | 1,012,790 | 1,076,578 | +6.3% | $4.2M |
| UPB UPSTREAM BIO INC | 341,779 | 350,389 | +2.5% | $2.4M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| IMUX IMMUNIC INC | 2,344,779 | 325,022 | -86.1% | $5.0M |
| CMPS COMPASS PATHWAYS PLC | 742,049 | 573,086 | -22.8% | $8.1M |
| ABEO ABEONA THERAPEUTICS INC | 1,329,899 | 983,070 | -26.1% | $6.1M |
| FDMT 4D MOLECULAR THERAPEUTICS IN | 380,420 | 252,654 | -33.6% | $3.4M |
| DCTH DELCATH SYSTEMS INC | 979,698 | 871,460 | -11.0% | $11.0M |
| CLDX CELLDEX THERAPEUTICS INC | 131,364 | 103,695 | -21.1% | $3.9M |
| CORT CORCEPT THERAPEUTICS INC | 147,828 | 136,499 | -7.7% | $11.9M |
| ZVRA ZEVRA THERAPEUTICS INC | 282,418 | 253,544 | -10.2% | $3.6M |
| EYPT EYEPOINT INC | 215,825 | 191,745 | -11.2% | $2.7M |
| OCUL OCULAR THERAPEUTIX INC | 382,375 | 357,966 | -6.4% | $3.5M |
| CRVS CORVUS PHARMACEUTICALS INC | 85,791 | 70,380 | -18.0% | $1.1M |
CIK 1969764 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
